Free Helpline
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
LCIS is a non-cancerous breast condition that increases future breast cancer risk. Learn about symptoms, diagnosis, treatment options, and the importance of screening.
Encountering a medical term like 'carcinoma' can instantly spark worry, and understandably so. When it comes to your breasts, any mention of such a term warrants attention. Today, we're going to talk about Lobular Carcinoma in Situ, or LCIS. Now, take a deep breath. Despite its name, LCIS is not cancer. It's a benign condition, meaning it's not life-threatening and doesn't actively spread. However, it's a crucial indicator that signals an increased risk of developing breast cancer in the future. Think of it as a warning sign, not the disease itself. Understanding LCIS, its implications, and how to manage it is vital for maintaining your breast health and peace of mind.
This condition most commonly affects premenopausal women, typically between the ages of 40 and 50. It's exceptionally rare in men. The diagnosis itself can be a bit confusing because 'carcinoma' usually means cancer. To clear things up, some healthcare professionals prefer to call it lobular neoplasia. 'Neoplasia' simply means abnormal cell growth, and 'in situ' means the abnormal cells are confined to their original location, not invading surrounding tissues. So, while LCIS sounds similar to invasive lobular breast cancer, they are distinctly different. LCIS is not breast cancer at all.
Let's break down the name: 'Lobular' refers to the lobules of the breast, which are the small glands responsible for producing milk. 'Carcinoma' typically denotes cancer, but as we've established, in LCIS, it signifies abnormal cell growth. 'In situ' means the cells are contained within the lobule and haven't spread. So, LCIS is an abnormal proliferation of cells within the breast lobules that has not invaded surrounding tissue.
It's essential to differentiate LCIS from Ductal Carcinoma In Situ (DCIS). DCIS involves abnormal cells found in the milk ducts, while LCIS involves abnormal cells in the lobules. DCIS is considered stage 0 breast cancer, sometimes called precancer, whereas LCIS is considered a risk factor for future breast cancer, not cancer itself.
One of the most challenging aspects of LCIS is that it usually doesn't cause any symptoms. You likely won't feel any pain or discomfort. Your breasts won't look or feel different. It rarely forms a lump that you can feel or that shows up on a standard screening mammogram. This silent nature is precisely why it's often discovered incidentally. How? Usually, it's found when a woman undergoes a breast biopsy for another reason – perhaps a concerning spot on a mammogram or a palpable lump that turns out to be benign, but the biopsy reveals LCIS.
Since LCIS often hides without symptoms and may not be visible on imaging, a biopsy is the only definitive way to diagnose it. During a biopsy procedure, a doctor uses a fine needle to collect a small sample of the suspicious breast tissue. This sample is then sent to a laboratory where a pathologist, a doctor specializing in diagnosing diseases by examining tissues, meticulously examines the cells under a microscope. They look for the characteristic abnormal cell growth within the lobules that defines LCIS.
While LCIS is not cancer, it's a significant marker for an increased risk of developing breast cancer later. Studies suggest that women with LCIS have a risk of developing invasive breast cancer that is about 7 to 12 times higher than women without LCIS. This increased risk is not immediate; it tends to manifest more prominently 10 years or more after the LCIS diagnosis, although it can occur sooner. It's also important to remember that even with this elevated risk, most women with LCIS will never develop breast cancer.
The risk applies to both breasts. The data from studies is reassuring regarding mortality. For instance, a 2017 study model indicated favorable 10-year and 20-year breast cancer-specific mortality rates for women diagnosed with LCIS. Many women diagnosed with LCIS actually passed away from other causes, not breast cancer. For those diagnosed at age 50, the 20-year breast cancer-specific mortality rate was less than 1 percent. In another cohort diagnosed at age 60, the 20-year breast cancer-specific mortality rate was even lower, between 0.12% and 1.14%. This highlights that while the risk is real, proactive management and regular screenings are highly effective.
Because LCIS is not cancer, active treatment isn't always necessary. The decision-making process is highly personalized and depends on several factors:
Your doctor might recommend removing the abnormal tissue. This can be done through:
In some cases, especially with other significant risk factors, a prophylactic mastectomy (surgical removal of the breast) might be considered to drastically reduce the risk of future breast cancer. However, this is not typically the first-line recommendation solely for LCIS. If a mastectomy is performed, both breasts would be considered for removal due to the bilateral risk associated with LCIS. Lymph node removal is generally not necessary as LCIS is not cancer.
Regardless of whether you choose active treatment for the LCIS itself, regular and vigilant follow-up screening is absolutely critical. Since LCIS indicates an increased risk for future breast cancer, you'll need a tailored screening schedule. This typically involves:
This heightened surveillance helps detect any potential future breast cancer at its earliest, most treatable stages.
While you can't change the fact that you have LCIS, you can adopt lifestyle choices that may help manage your overall breast cancer risk. These include:
While LCIS itself doesn't present symptoms, you should always consult your doctor if you notice any changes in your breasts, such as:
These symptoms could indicate a new issue, and prompt medical evaluation is essential.
No, LCIS is not cancer. It is a benign breast condition that indicates an increased risk of developing breast cancer in the future.
LCIS itself does not turn into cancer. However, it is a marker that you have a higher risk of developing invasive breast cancer in either breast later on.
LCIS (Lobular Carcinoma In Situ) involves abnormal cells in the milk-producing lobules, while DCIS (Ductal Carcinoma In Situ) involves abnormal cells in the milk ducts. DCIS is considered stage 0 breast cancer, whereas LCIS is a risk factor.
Surgery is not always necessary for LCIS. The decision depends on individual factors like the degree of cellular abnormality and personal/family history of breast cancer. Options range from observation to tissue removal.
Your screening schedule will be personalized by your doctor. It typically involves more frequent mammograms and may include other imaging like breast MRI.
Debunking the myth that Vitamin C can induce an abortion. Learn about safe, FDA-approved medication abortion and how to access it with support.
April 1, 2026
Feeling exhausted before your period is common. Learn about the causes of PMS fatigue and practical strategies, including diet, sleep, exercise, and stress management, to boost your energy levels and well-being.
April 1, 2026
Considering a clitoral piercing? Learn about the different types, the procedure, jewelry materials, healing, aftercare, and potential risks. Make an informed decision for your safety and satisfaction.
April 1, 2026